Position in CYTK
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$128,663,982
+$29,464,496 QoQ
Shares Held
1,510,318
+0.3% QoQ
Ownership
1.09%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#23
of 477 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 81%
Shared 0%
None 19%
Common Shares in CYTK Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MORGAN STANLEY holds $16,717,848,792 across 523 Biotechnology names. CYTK ranks #25 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
42,931,597 | $2,407,174,637 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,242,139 | $1,610,467,694 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
42,592,905 | $1,507,362,901 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,397,712 | $871,529,332 | |
| 5 | MRNA |
Moderna, Inc.
|
9,538,094 | $667,952,718 | |
| 6 | ARGX |
Argenx SE
|
643,123 | $596,670,219 | |
| 7 | TECH |
BIO-TECHNE Corp
|
6,374,717 | $450,373,747 | |
| 8 | INCY |
Incyte Corp
|
2,948,364 | $334,226,536 |
All Filings in CYTK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $128,663,982 | 1,510,318 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $99,199,486 | 1,505,075 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $80,397,221 | 1,265,301 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $83,604,377 | 1,521,186 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $36,941,359 | 1,118,080 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $40,662,028 | 1,011,745 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $58,940,552 | 1,252,988 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $61,690,037 | 1,168,372 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $59,905,412 | 1,105,674 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $66,945,090 | 954,858 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $200,508,077 | 2,401,582 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $30,997,985 | 1,052,206 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $29,627,143 | 908,251 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $28,582,862 | 812,244 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $58,001,791 | 1,265,862 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $68,332,230 | 1,410,366 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $58,939,121 | 1,500,105 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $43,097,845 | 1,170,819 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $39,730,348 | 871,662 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $30,054,621 | 840,924 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $18,403,905 | 929,960 | Shares | Defined | 2021-08-23 | |
| 2021-03-31 | $16,356,825 | 703,217 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $18,591,387 | 894,677 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $18,209,316 | 841,077 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $16,611,829 | 704,787 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $11,337,911 | 961,655 | Shares | Defined | 2020-05-26 | |
| No filing history on record for this holder in this stock. | ||||||